Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: A biopsy study in chronic prostatitis patients

Vral,A.; Magri,V.; Montanari,E.; Gazzano,G.; Gourvas,V.; Marras,E.; Perletti,G.

doi:10.3892/ijo.2012.1646

Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: A biopsy study in chronic prostatitis patients

Authors:
- A. Vral
- V. Magri
- E. Montanari
- G. Gazzano
- V. Gourvas
- E. Marras
- G. Perletti
View Affiliations

Affiliations: Section of Histology, Department of Basic Medical Sciences, Ghent University, Ghent, Belgium, Urology Secondary Care Clinic, Azienda Ospedaliera Istituti Clinici di Perfezionamento, Milan, Italy, Department of Urology, San Paolo Hospital/University of Milan, Milan, Italy, Division of Pathology and Cytodiagnostics, M. Mellini Hospital, Chiari, Italy, Department of Pathology, General Hospital ‘G. Gennimatas’, Thessaloniki, Greece, Biomedical Research Division, Department of Theoretical and Applied Sciences, University of Insubria, Busto A/Varese, Italy
Published online on: October 1, 2012 https://doi.org/10.3892/ijo.2012.1646
Pages: 1950-1958
Copyright: © Vral et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Inflammatory processes are important components in the pathogenesis of many human cancers. According to the ‘injury and regeneration’ model for prostate carcinogenesis, injury caused by pathogens or pro-inflammatory cytotoxic agents would trigger proliferation of prostatic glandular cells, leading to the appearance of epithelial lesions named ‘Proliferative Inflammatory Atrophy’ (PIA). Inflammatory cells infiltrating the prostate would release genotoxic reactive oxygen species, leading atrophic cells to neoplastic progression. The hypothesis pointing to PIA as risk-lesion for prostate cancer has been extensively investigated at the cellular and molecular levels, but few morphological data are available linking PIA or prostatic intraepithelial neoplasia (PIN) to inflammation or clinical prostatitis. We investigated at the morphological level 1367 prostate biopsies from 98 patients with a recent history of chronic prostatitis, and 32 patients with biopsies positive for carcinoma. Our results show that i) PIA is found more frequently in biopsy cores containing a severe or moderate inflammatory focus, compared to NON-PIA lesions (partial or cystic atrophy); ii) the PIA lesion post-atrophic hyperplasia is more frequently found in tissues showing mild or no inflammation; iii) the extent of PIA per patient correlates with the burden of moderate or severe inflammation, whereas NON-PIA lesions do not; iv) low-grade PIN is in over 90% of cases emerging from normal, non-atrophic glands and is more frequently found in biopsy cores with absent or mild inflammatory burden; v) the inverse relationship between the prevalence of low-grade PIN and the extent of PIA lesions per patient is described by a power law function, suggesting the low likelihood of the concomitant presence of these lesions in the same tissue; vi) NON-PIA lesions correlate inversely with neoplasia in patients with prostate cancer; vii) the total scores of the NIH-CPSI questionnaire correlate with both PIA and inflammation burdens at diagnosis of prostatitis but not after pharmacological intervention. These results point to a positive association between tissue inflammation, clinical prostatitis and the putative cancer risk-lesion PIA, but do not support a model whereby low-grade PIN would arise from PIA.

View Figures

View References

1.	A MantovaniP AllavenaA SicaF BalkwillCancer-related inflammationNature454436444200810.1038/nature07205
2.	I ChengJS WitteSJ JacobsenProstatitis, sexually transmitted diseases, and prostate cancer: the California Men’s Health StudyPLoS One5e87362010
3.	S JafariM EtminanK AfsharNonsteroidal anti-inflammatory drugs and prostate cancer: a systematic review of the literature and meta-analysisCan Urol Assoc J3323330200919672448
4.	AM De MarzoEA PlatzS SutcliffeInflammation in prostate carcinogenesisNat Rev Cancer72562692007
5.	G PerlettiE MontanariA VralG GazzanoE MarrasS MioneV MagriInflammation, prostatitis, proliferative inflammatory atrophy: ‘Fertile ground’ for prostate cancer development?Mol Med Rep33122010
6.	ON KryvenkoM JankowskiDA ChitaleD TangA RundleS TrudeauBA RybickiInflammation and preneoplastic lesions in benign prostate as risk factors for prostate cancerMod Pathol2510231032201210.1038/modpathol.2012.5122460812
7.	S DavidssonM FiorentinoO AndrénInflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancerCancer Epidemiol Biomarkers Prev2022802287201110.1158/1055-9965.EPI-11-0373
8.	MJ PutziAM De MarzoMorphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasiaUrology56828832200010.1016/S0090-4295(00)00776-7
9.	W WangA BerghJE DamberMorphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostateProstate6913781386200910.1002/pros.2099219507201
10.	A BillisLL FreitasLA MagnaU FerreiraInflammatory atrophy on prostate needle biopsies: is there topographic relationship to cancer?Int Braz J Urol33355360200710.1590/S1677-55382007000300008
11.	AA BrasilWJ FavaroVH CagnonU FerreiraA BillisAtrophy in specimens of radical prostatectomy: is there topographic relation to high grade prostatic intraepithelial neoplasia or cancer?Int Urol Nephrol43397403201110.1007/s11255-010-9803-y
12.	A BillisProstatic atrophy. Clinicopathological significanceInt Braz J Urol36401409201010.1590/S1677-5538201000040000320815946
13.	RC AntonMW KattanS ChakrabortyTM WheelerPostatrophic hyperplasia of the prostate: lack of association with prostate cancerAm J Surg Pathol23932936199910.1097/00000478-199908000-0001110435563
14.	R PostmaFH SchröderTH van der KwastAtrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened menUrology65745749200510.1016/j.urology.2004.10.04615833520
15.	G MikuzF AlgabaAL BeltranR MontironiProstate carcinoma: atrophy or not atrophy that is the questionEur Urol5212931296200710.1016/j.eururo.2007.07.03917761384
16.	R MontironiR MazzucchelliA Lopez-BeltranL ChengM ScarpelliMechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostateNat Clin Pract Urol4321332200710.1038/ncpuro081517551536
17.	KS SfanosAM De MarzoProstate cancer and inflammation: the evidenceHistopathology60199215201210.1111/j.1365-2559.2011.04033.x22212087
18.	S Yildiz-SezerI VerdorferG SchaeferH RogatschG BartschG MikuzAssessment of aberrations on chromosome 8 in prostatic atrophyBJU Int98184188200610.1111/j.1464-410X.2006.06233.x16831166
19.	JA MacoskaTM TrybusKJ Wojno8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancerUrology55776782200010.1016/S0090-4295(00)00468-410792100
20.	R ShahNR MucciA AminJA MacoskaMA RubinPostatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?Am J Pathol15817671773200110.1016/S0002-9440(10)64132-611337374
21.	S Yildiz-SezerI VerdorferG SchaeferH RogatschG BartschG MikuzGain of chromosome X in prostatic atrophy detected by CGH and FISH analysesProstate67433438200710.1002/pros.2053517219381
22.	KS SfanosBA WilsonAM De MarzoWB IsaacsAcute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancerProc Natl Acad Sci USA10634433448200910.1073/pnas.081047310619202053
23.	M ScarpelliR MazzucchelliF BarbisanA SantinelliA Lopez-BeltranL ChengR MontironiIs there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemaseInt J Immunopathol Pharmacol256774201222507319
24.	V FradetI ChengG CaseyJS WitteDietary omega-3 fatty acids, cycloxygenase-2 genetic variation, and aggressive prostate cancer riskClin Cancer Res1525591566200910.1158/1078-0432.CCR-08-250319318492
25.	JN KriegerL Nyberg JrJC NickelNIH consensus definition and classification of prostatitisJAMA282236237199910.1001/jama.282.3.23610422990
26.	V MagriE MontanariV ŠkerkFluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunctionAsian J Androl13819827201110.1038/aja.2011.36
27.	V MagriA TrinchieriE MontanariReduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detectionArch Ital Urol Androl7984922007
28.	JC NickelLD TrueJN KriegerRE BergerAH BoagID YoungConsensus development of a histopathological classification system for chronic prostatic inflammationBJU Int87797805200110.1046/j.1464-410x.2001.02193.x11412216
29.	L SongY ZhuP HanN ChenD LinJ LaiQ WeiA retrospective study: correlation of histologic inflammation in biopsy specimens of Chinese men undergoing surgery for benign prostatic hyperplasia with serum prostate-specific antigenUrology77688692201110.1016/j.urology.2010.07.493
30.	AM De MarzoEA PlatzJI EpsteinA working group classification of focal prostate atrophy lesionsAm J Surg Pathol3012811291200617001160
31.	A BillisL MeirellesLL FreitasLA MagnaU FerreiraDoes the type of prostatic atrophy influence the association of extent of atrophy in needle biopsies and serum prostate-specific antigen levels?Urology7411111115200910.1016/j.urology.2009.05.093
32.	R MontironiR MazzucchelliF AlgabaA Lopez-BeltranMorphological identification of the patterns of prostatic intraepithelial neoplasia and their importanceJ Clin Pathol53655665200010.1136/jcp.53.9.65511041054
33.	R MontironiM ScarpelliR MazzucchelliL ChengA Lopez-BeltranThe spectrum of morphology in non-neoplastic prostate including cancer mimicsHistopathology604158201210.1111/j.1365-2559.2011.04000.x22212077
34.	MS LitwinM McNaughton-CollinsFJ Fowler JrThe National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measureJ Urol162369375199910.1016/S0022-5347(05)68562-X
35.	F YatesContingency tables involving small numbers and the χ² testJ R Stat Soc12172351934
36.	A BillisLA MagnaInflammatory atrophy of the prostate. Prevalence and significanceArch Pathol Lab Med127840844200312823038
37.	KM RuskaJ SauvageotJI EpsteinHistology and cellular kinetics of prostatic atrophyAm J Surg Pathol2210731077199810.1097/00000478-199809000-000059737239
38.	JE McNealNormal histology of the prostateAm J Surg Pathol12619633198810.1097/00000478-198808000-000032456702
39.	JR SrigleyBenign mimickers of prostatic adenocarcinomaMod Pathol17328348200410.1038/modpathol.3800055
40.	A BillisL MeirellesLL FreitasMergence of partial and complete atrophy in prostate needle biopsies: a morphologic and immunohistochemical studyVirchows Arch456689694201010.1007/s00428-010-0904-x20361207
41.	Foundations of Clinical Research: Applications and PracticeLG PortneyMP WatkinsAppleton & LangeNorwalk, Connecticut5095161993